Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Natco
FDA Approves POMALIDOMIDE — Natco Pharma Limited

On October 30, 2020, Natco Pharma Limited received approval from the FDA for its generic version of the oral drug pomalidomide under ANDA210111, a mov...

Accord
FDA Approves FINGOLIMOD HYDROCHLORIDE — Accord Healthcare Inc.

Accord Healthcare Inc. has received FDA approval for the Abbreviated New Drug Application (ANDA207991) for oral fingolimod hydrochloride, introducing ...

Accord
FDA Approves METHYLPHENIDATE HYDROCHLORIDE — Accord Healthcare, Inc.

FDA has granted tentative approval to Accord Healthcare, Inc.’s ANDA for methylphenidate hydrochloride tablets, a generic version of the drug known by...

Leading
FDA Approves LEUCOVORIN CALCIUM — Leading Pharma, LLC

Leading Pharma, LLC received FDA approval for generic oral Leucovorin Calcium, introducing a new entrant that is expected to intensify competition and...

Gilead
FDA Approves VEKLURY — Gilead Sciences, Inc.

The FDA’s approval of Gilead Sciences, Inc.’s intravenous remdesivir (VEKLURY) marks a significant milestone for the company’s antiviral portfolio, po...

Harmony
FDA Approves WAKIX — Harmony Biosciences, LLC

# FDA Approves Harmony Biosciences' WAKIX for Narcolepsy Treatment Harmony Biosciences announced FDA approval of WAKIX (pitolisant hydrochloride), an...

Lifestar
FDA Approves ACETAZOLAMIDE — Lifestar Pharma LLC

# FDA Approves Lifestar Pharma's Generic Acetazolamide The U.S. Food and Drug Administration has approved Lifestar Pharma LLC's abbreviated new drug ...

SpecGx
FDA Approves DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE — SpecGx LLC

SpecGx LLC has secured FDA approval for the generic oral formulation of Diphenoxylate Hydrochloride and Atropine Sulfate, positioning the company to e...

Pfizer
FDA Approves XELJANZ — Pfizer Laboratories Div Pfizer Inc

Pfizer’s FDA approval of XELJANZ reinforces its competitive position in the rheumatology market, expected to drive incremental sales growth as it capt...

Avet
FDA Approves ACYCLOVIR — Avet Pharmaceuticals Inc.

Avet Pharmaceuticals Inc. announced FDA approval of its Abbreviated New Drug Application for oral acyclovir, potentially strengthening its position in...

Granules
FDA Approves DEXMETHYLPHENIDATE HYDROCHLORIDE — Granules Pharmaceuticals Inc.

Granules Pharmaceuticals Inc. received approval for its ANDA 213813 to manufacture and market Dexmethylphenidate Hydrochloride, the active ingredient ...

Hikma
FDA Approves FOSAPREPITANT DIMEGLUMINE — Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. announced the approval of its generic fosaprepitant dimeglumine intravenous injection by the FDA, a motion sickness ant...

Celgene
FDA Approves ONUREG — Celgene Corporation

# FDA Approves Celgene's ONUREG (Azacitidine) as First Oral Maintenance Therapy for AML The FDA approval of Celgene Corporation's ONUREG (azacitidine...

TruPharma,
FDA Approves TRAMADOL HYDROCHLORIDE — TruPharma, LLC

TruPharma, LLC announced on Monday the implementation of the 180-day generic exclusivity period for its 50 mg and 100 mg oral tramadol hydrochloride t...

ACCORD
FDA Approves Unknown Drug — ACCORD HLTHCARE

Accord Healthcare announced FDA approval for a new drug application on Aug. 24, 2020, which market analysts expect to broaden the company’s product po...

Zhejiang
FDA Approves GABAPENTIN — Zhejiang Yongtai Pharmaceutical Co., Ltd

# FDA Approves Generic Gabapentin from Zhejiang Yongtai Pharmaceutical The U.S. Food and Drug Administration has approved Zhejiang Yongtai Pharmaceut...

Genentech,
FDA Approves ENSPRYNG — Genentech, Inc.

# FDA Approves Genentech's ENSPRYNG for Neuromyelitis Optica Spectrum Disorder The FDA has approved Genentech's ENSPRYNG (satralizumab), a subcutaneo...

Genentech,
FDA Approves EVRYSDI — Genentech, Inc.

# FDA Approves Genentech's EVRYSDI (risdiplam) for Spinal Muscular Atrophy Genentech announced FDA approval of EVRYSDI (risdiplam), an oral treatment...

Astellas
FDA Approves XTANDI — Astellas Pharma US, Inc.

Astellas Pharma Inc. received FDA approval for its oral androgen receptor antagonist Enzalutamide, assigned the brand name XTANDI, to treat certain me...

CONCORD
FDA Approves MYCOPHENOLATE MOFETIL — CONCORD BIOTECH LIMITED

Concord Biotech Limited won approval for its ANDA212087 on July 31, 2020, for the oral product Mycophenolate Mofetil, indicating the company is positi...